P1.01-037 Circulating Tumor DNA Clearance During Treatment Associates With Improved Progression-Free Survival

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2017.09.691
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P1.01-46 Circulating Tumor DNA Analysis for Predicting Response to Osimertinib and Disease Progression in EGFR-Mutant Non-Small-Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Association ofEGFRL858R Mutation in Circulating Free DNA With Survival in the EURTAC Trial

JAMA Oncology
Cancer ResearchOncology
2015English

Circulating Cell-Free DNA and Circulating Tumor Cells, the “Liquid Biopsies” in Ovarian Cancer

Journal of Ovarian Research
GynecologyOncologyObstetrics
2017English

P1.01-77 Osimertinib in the First-Line Treatment of Non-Small Cell Lung Cancer Harboring Activating EGFR Mutation From Circulating Tumor DNA

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Circulating Cell-Free DNA

2019English

P2.04-02 Predictive Value of Circulating Tumor Cells and Circulating Free DNA in NSCLC Patients Treated With Nivolumab

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Circulating Tumor Cells and Melanoma Progression

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2010English

Clearance of Circulating DNA-anti-DNA Immune Complexes in Mice

Journal of Experimental Medicine
MedicineAllergyImmunology
1982English

Toward Liquid Biopsies in Cancer Treatment: Application of Circulating Tumor DNA

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
ImmunologyAllergyMicrobiologyMedicineForensic MedicinePathology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy